Retour
Également cotée sous
HMDCF
OTC
Fourchette du Jour
13,91 €
14,21 €
Fourchette 52 Semaines
11,51 €
19,50 €
Volume
10 615
Moyenne 50J / 200J
14,74 €
/
15,33 €
Clôture Précédente
14,12 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 5,6 | 0,2 |
| P/B | 2,1 | 3,0 |
| ROE % | 45,9 | 3,6 |
| Net Margin % | 83,3 | 3,8 |
| Rev Growth 5Y % | 11,5 | 9,9 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
17,50 €
+23.7%
P/E Prévisionnel
44,61
BPA Prévisionnel
0,32 €
Croissance BPA (est.)
+0,0%
CA Est.
640,33M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,17 €
1,09 € – 1,35 €
|
1,18B | 1 |
| FY2029 |
0,88 €
0,82 € – 1,02 €
|
1,05B | 1 |
| FY2028 |
0,60 €
0,56 € – 0,69 €
|
843,53M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-08-07 | 1,46 € | 1,30 € | -11,0% |
| 2025-07-02 | N/A | 1,30 € | — |
| 2025-03-19 | -0,09 € | 0,03 € | +137,9% |
| 2024-09-30 | N/A | 0,03 € | — |
| 2024-07-31 | N/A | 0,01 € | — |
| 2024-06-10 | N/A | 0,07 € | — |
| 2024-02-28 | -1,08 € | -0,04 € | +96,3% |
| 2023-07-31 | N/A | 0,10 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 11,48% annually over 5 years — strong growth
Earnings grew 1114,23% over the past year
ROE of 45,86% indicates high profitability
Net margin of 83,30% shows strong profitability
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -79,01M
Croissance
Revenue Growth (5Y)
11,48%
Revenue (1Y)-12,73%
Earnings (1Y)1114,23%
FCF Growth (3Y)N/A
Qualité
Return on Equity
45,86%
ROIC-3,07%
Net Margin83,30%
Op. Margin-9,95%
Sécurité
Debt / Equity
0,08
Current Ratio4,96
Interest Coverage-19,05
Valorisation
P/E Ratio
5,58
Forward P/E44,61
P/B Ratio2,06
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12,73% | Revenue Growth (3Y) | -18,99% |
| Earnings Growth (1Y) | 1114,23% | Earnings Growth (3Y) | 113,21% |
| Revenue Growth (5Y) | 11,48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 549,96M | Net Income (TTM) | 458,12M |
| ROE | 45,86% | ROA | 26,13% |
| Gross Margin | 38,68% | Operating Margin | -9,95% |
| Net Margin | 83,30% | Free Cash Flow (TTM) | -79,01M |
| ROIC | -3,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 4,96 |
| Interest Coverage | -19,05 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 5,58 | Forward P/E | 44,61 |
| P/B Ratio | 2,06 | P/S Ratio | 4,65 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3,99 | Fwd Earnings Yield | 2,24% |
| FCF Yield | -3,09% | ||
| Market Cap | 2,56B | Enterprise Value | 2,58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 549,96M | 630,20M | 838,00M | 426,41M | 356,13M |
| Net Income | 458,12M | 37,73M | 100,78M | -360,84M | -194,65M |
| EPS (Diluted) | 2,60 | 0,22 | 0,60 | -2,15 | -1,25 |
| Gross Profit | 212,72M | 281,32M | 453,55M | 115,31M | 97,89M |
| Operating Income | -54,73M | -43,71M | 18,38M | -409,77M | -344,29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,75B | 1,27B | 1,28B | 1,03B | 1,37B |
| Total Liabilities | 501,84M | 502,34M | 536,39M | 392,58M | 333,15M |
| Shareholders' Equity | 1,24B | 759,93M | 730,54M | 610,37M | 986,89M |
| Total Debt | 97,89M | 89,82M | 86,13M | 27,01M | 38,98M |
| Cash & Equivalents | 71,33M | 153,96M | 283,59M | 313,28M | 377,54M |
| Current Assets | 1,57B | 1,07B | 1,10B | 839,89M | 1,21B |
| Current Liabilities | 315,78M | 376,56M | 403,03M | 353,90M | 311,66M |
Scores de Stratégies
This stock passed the criteria for 0 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026